Lupin’s Vinita Gupta honoured as CNBC Changemaker for revolutionising U.S. healthcare access
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Nadda underlined that India’s policy framework is aligned with this transformation
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
The company’s EBITDA margin remained resilient above 20%
HCG clinicians contributing to one of the largest bodies of oncology research from India
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
Subscribe To Our Newsletter & Stay Updated